血栓弹力图市场:按类型、按应用、按最终用户、按地区 - 规模、份额、展望、机会分析,2022-2030
市场调查报告书
商品编码
1213967

血栓弹力图市场:按类型、按应用、按最终用户、按地区 - 规模、份额、展望、机会分析,2022-2030

Thromboelastography Market, By Type, By Application, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 159 Pages | 商品交期: 2-3个工作天内

价格
简介目录

血栓弹力图是一项保护您自己免受严重受伤或手术期间发生的严重出血的测试。 血栓弹力图(TEG)是体外综合分析血小板、□、纤维蛋白原和其他凝血元素之间的关係,在移植、动静脉畸形手术中应用较多。 血小板图谱可以评估服用氯□格雷和阿司匹林等抗凝剂的患者的血小板活性。 通过将 TEG 纳入麻醉前评估,这成为可能。

市场动态

市场参与者加大开发新技术的力度,预计将在预测期内推动全球血栓弹力图市场的增长。 例如,2022 年 2 月 20 日,美国国家医学图书馆发表的一篇文章认为,凝血障碍给耳鼻喉头颈外科 (ENT) 领域带来了额外的诊断和治疗困难。底部。 高凝和低凝患者的凝血病管理需要仔细考虑止血能力的性质。 粘弹性研究 (VET),例如血栓弹力图 (TEG) 和旋转血栓弹力图 (ROTEM),长期以来一直被用作指导血液成分治疗 (BCT) 的方法。 VET 被广泛用于诊断和管理外伤引起的凝血病和出血状况。

美国 FDA 等监管机构的新批准率不断提高,这可能会在预测期内推动全球血栓弹力图市场的增长。 例如,2021 年 1 月 11 日,雅培是一家从事医疗器械和保健品製造和研究的跨国公司。 雅培 (Abbott) 已获得 FDA 510(k) 许可,可用于首次针对脑震荡的快速手持式血液检测。 雅培的 i-STAT Alinity 手持设备将用于为轻度创伤性脑损伤 (TBI)(称为脑震盪)提供诊断测试。 插入血浆样本后 15 分钟即可获得测试结果。

研究的主要特征

  • 本报告对全球血栓弹力图市场进行了深入分析,包括以 2021 年为基准年的预测期(2022-2030 年)的市场规模(百万美元)和復合年增长率 (CAGR%)。 .
  • 它揭示了不同细分市场的潜在收入机会,并为该市场概述了一个有吸引力的投资建议矩阵。
  • 它还提供了有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争战略等方面的重要见解。
  • 它根据以下参数介绍了全球血栓弹力图市场的主要参与者:公司亮点、产品组合、主要亮点、财务业绩和战略。
  • 本研究涵盖的主要公司包括乐普医疗科技(北京)有限公司、Render Biotech Co.、Haemonetics Corporation、TA Instruments、HemaCore LLC、5-Diagnostics、Xenometrix AG、Framar Hemologix srl、Instrumentation Laboratory, Medirox AB, Diagnostica Stago, Life Diagnostica, SYCOmed e.K., Nordic Biomarker, and Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.
  • 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。我猜。
  • 本研究报告面向该行业的各种利益相关者,包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以通过用于分析全球血栓弹力图市场的各种战略矩阵来促进他们的决策。

内容

第 1 章目的和先决条件

  • 调查目的
  • 先决条件
  • 缩写说明

第二章市场展望

  • 报告内容
    • 市场定义和范围
  • 执行摘要
    • 市场概况:按类型分类
    • 市场概况:按应用分类
    • 市场概况:按最终用户分类
    • 市场概况:按地区
  • 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

  • 市场动态
    • 司机
    • 约束因素
    • 商机
  • 影响分析
  • 主要发展状况
  • 行业趋势
  • 监管场景
  • 最近的产品批准/发布
  • 害虫分析
  • 搬运工分析

第 4 章全球血栓弹力图市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 对需求的影响
  • 对医疗保健的影响
  • 流行病学

第 5 章全球血栓弹力图市场类型,2017-2030

  • 标准(高岭土)
  • 快速 TEG
  • 本地 TEG
  • 肝素□
  • 功能性纤维蛋白原
  • 血小板绘图

第 6 章全球血栓弹力图市场:按应用,2017-2030

  • 体外循环
  • 肝臟手术
  • 创伤外科
  • 产科

第 7 章。全球血栓弹力图市场:按最终用户分类,2017-2030

  • 医院
  • 血库
  • 学术机构
  • 其他(实验室、研究所)

第 8 章。全球血栓弹力图市场:地区,2017-2030

  • 北美
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲地区
  • 欧洲
  • 德国
  • 英国
  • 法国
  • 意大利
  • 西班牙
  • 俄罗斯
  • 其他欧洲地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 韩国
  • 东盟
  • 其他亚太地区
  • 中东
  • 海湾合作委员会
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 中非
  • 北非

第9章竞争格局

  • 热图分析
  • 市场份额分析
    • Lepu Medical Technology(Beijing)Co.,Ltd.
    • Render Biotech Co.
    • Haemonetics Corporation
    • TA Instruments
    • HemaCore LLC
    • 5-Diagnostics
    • Xenometrix AG
    • Framar Hemologix srl
    • Instrumentation Laboratory
    • Medirox AB
    • Diagnostica Stago
    • Life Diagnostica
    • SYCOmed e.K.
    • Nordic Biomarker
    • Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.

第 10 章

  • 调查方法介绍
  • 关于出版商
简介目录
Product Code: CMI2371

The thromboelastography protects against the severe blood loss or hemorrhage occurred during severe injury or during a surgery. Thromboelastography (TEG) is more frequently used in cardiac surgery, organ transplants, and arteriovenous malformation surgeries where the anticipated blood loss is greater than 40% of the circulating blood volume because it performs an in vitro analysis of the relationship between platelets, enzymes, fibrinogen, and other coagulation elements in a comprehensive manner. Through platelet mapping, patients using antiaggregants like clopidogrel or aspirin can have their platelet activity assessed. This is made possible by include TEG in the pre-anesthetic assessment.

Market Dynamics

Increasing initiatives in developing new methods by market players is expected to boost the growth of global thromboelastography market over the forecast period. For instance, on February 20, 2022, an article published in national library of medicine, asserted that Coagulopathies pose additional diagnostic and therapeutic difficulties in the field of otolaryngology-head and neck surgery (ENT). Management of coagulopathies in both hyper- and hypocoagulable individuals necessitates careful consideration of the nature of hemostatic competence. Viscoelastic tests (VETs) such as thromboelastography (TEG) and rotational thromboelastometry (ROTEM) have long been methods of guiding blood component therapy (BCT). VETs have been widely adopted for the diagnosis and management of trauma-induced coagulopathy and bleeding conditions.

Increasing in the rate of new approvals by regulatory authorities such as the U.S. FDA is likely to boost the growth of global thromboelastography market over the forecast period. For instance, on January 11, 2021, Abbott Laboratories is a multinational company engaged in manufacturing and research of medical devices and health care products. Abbott received an FDA 510(k) clearance for the first rapid handheld blood test for concussion. The i-STAT Alinity handheld device from Abbott will be used to provide the test to help diagnose mild traumatic brain injury (TBI), also known as concussion. The test results are available 15 minutes after inserting a plasma sample.

Key features of the study:

  • This report provides an in-depth analysis of the global thromboelastography market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global thromboelastography market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
  • Key companies covered as a part of this study include Lepu Medical Technology (Beijing) Co.,Ltd., Render Biotech Co., Haemonetics Corporation, TA Instruments, HemaCore LLC, 5-Diagnostics, Xenometrix AG, Framar Hemologix srl, Instrumentation Laboratory, Medirox AB, Diagnostica Stago, Life Diagnostica, SYCOmed e.K., Nordic Biomarker, and Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global thromboelastography market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global thromboelastography market

Detailed Segmentation:

  • Global Thromboelastography Market, by Type:
    • Standard (kaolin)
    • Rapid TEG
    • Native TEG
    • Heparinase
    • Functional Fibrinogen
    • Platelet Mapping
  • Global Thromboelastography Market, by Application :
    • Cardiopulmonary Bypass
    • Liver Surgery
    • Trauma surgery
    • Obstetrics
  • Global Thromboelastography Market, by End User :
    • Hospitals
    • Blood Banks
    • Academic Institutes
    • Others (Research Laboratories, Research Institutes)
  • Global Thromboelastography Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Lepu Medical Technology (Beijing) Co.,Ltd *
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Render Biotech Co.
    • Haemonetics Corporation
    • TA Instruments
    • HemaCore LLC
    • 5-Diagnostics
    • Xenometrix AG
    • Framar Hemologix srl
    • Instrumentation Laboratory
    • Medirox AB
    • Diagnostica Stago
    • Life Diagnostica
    • SYCOmed e.K.
    • Nordic Biomarker
    • Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Industry Trends
  • Regulatory Scenario
  • Recent Product Approval/Launches
  • PEST Analysis
  • Porter's Analysis

4. Global Thromboelastography Market- Impact of Coronavirus (COVID-19) Pandemic

  • Impact on Demand
  • Impact on Healthcare
  • Epidemiology

5. Global Thromboelastography Market, By Type, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Standard (kaolin)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Rapid TEG
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
  • Native TEG
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Heparinase
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Functional Fibrinogen
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
  • Platelet Mapping
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

6. Global Thromboelastography Market, By Application, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Cardiopulmonary Bypass
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Liver Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
  • Trauma surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Obstetrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)

7. Global Thromboelastography Market, By End User, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Blood Banks
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
  • Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Others (Research Laboratories, Research Institutes)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

8. Global Thromboelastography Market, By Region, 2017 - 2030 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030(%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2030
    • Regional Trends
  • North America
    • Market Size and Forecast, By Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • U.S.
  • Canada
  • Latin America
    • Market Size and Forecast, By Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Region/Country, 2017 - 2030 (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Lepu Medical Technology (Beijing) Co.,Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Render Biotech Co.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Haemonetics Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • TA Instruments
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • HemaCore LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • 5-Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Xenometrix AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Framar Hemologix srl
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Instrumentation Laboratory
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Medirox AB
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Diagnostica Stago
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Life Diagnostica
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • SYCOmed e.K.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Nordic Biomarker
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About Us